Subsidiary of Shanghai Kehua Bio-engineering (002022.SZ) obtains a medical device registration certificate.

15:48 09/12/2025

Kohwa Biological (002022.SZ) announced that its wholly-owned subsidiary Kohwa (Xi'an) Biotechnology Co., Ltd. has received a medical device registration certificate from the Drug Administration of Shaanxi Province for its product named: Fully Automated Chemiluminescence Immunoassay Analyzer.

Shanghai Kehua Bio-engineering (002022.SZ) announced that its wholly-owned subsidiary, Kehua (Xi'an) Bioengineering Co., Ltd., has received a medical device registration certificate issued by the Shaanxi Provincial Food and Drug Administration. The product name is: Fully automated chemiluminescence immunoassay analyzer.

Synopsys, Inc. (SNPS.US) "AI gear shifting" strategy taking effect: Joining forces with NVIDIA Corporation to boost performance, guidance exceeds expectations.

Adobe (ADBE.US) Q4 performance and 2026 fiscal year guidance both exceeded expectations, but market anxiety about AI disruption remains difficult to dispel.

Zhii Mining (02546) will conduct a global public offering of 122 million H shares from December 11th to December 16th, introducing cornerstone investors such as Spaco.

Synopsys, Inc. (SNPS.US) "AI gear shifting" strategy taking effect: Joining forces with NVIDIA Corporation to boost performance, guidance exceeds expectations.

Adobe (ADBE.US) Q4 performance and 2026 fiscal year guidance both exceeded expectations, but market anxiety about AI disruption remains difficult to dispel.

Zhii Mining (02546) will conduct a global public offering of 122 million H shares from December 11th to December 16th, introducing cornerstone investors such as Spaco.